PATENT CLAIM ANALYSIS

Application Number: 15961259
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "456000"]

Abstract:
Provided herein is a pharmaceutical composition comprising an isoflavonoid derivative and a cyclodextrin. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions. In specific instances, provided herein are intravenous compositions and therapies.

Claim (Index 6):
The composition of any of  claims 1 - 5 , wherein the cyclodextrin is selected from the group consisting of SAE-CD derivatives, SBE-\u03b1-CD, SBE-\u03b2-CD, SBE1-\u03b2-CD, SBE4-\u03b2-CD, SBE7-\u03b2-CD, SBE-\u03b3-CD, hydroxypropyl-\u03b2-cyclodextrin, 2-HP-\u03b2-CD, hydroxyethyl-\u03b2-cyclodextrin, hydroxypropyl-\u03b3-cyclodextrin, hydroxyethyl-\u03b3-cyclodextrin, dihydroxypropyl-\u03b2-cyclodextrin, glucosyl-\u03b1-cyclodextrin, glucosyl-\u03b2-cyclodextrin, diglucosyl-\u03b2-cyclodextrin, maltosyl-\u03b1-cyclodextrin, maltosyl-\u03b2-cyclodextrin, maltosyl-\u03b3-cyclodextrin, maltotriosyl-\u03b2-cyclodextrin, maltotriosyl-\u03b3-cyclodextrin, dimaltosyl-\u03b2-cyclodextrin, methyl-\u03b2-cyclodextrin, and derivatives and/or combinations thereof.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 91.0
- Lexical Diversity: 1.42857
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15622569', '13881599', '13881609', '15456182', '11413597']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8033019218978755
- 35 USC 102 Novelty (BERT): 0.5589544958068909
- Combined Prediction Score: 0.7788671792887771
- Mean Citation Score: 282.578344
- Max Citation Score: 405.76077
- Similarity Product: 348.3067811189997

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test